##fileformat=VCFv4.1
##source=VarSeqV2.5.0
##fileDate=20230918
##INFO=<ID=Type,Number=1,Type=String,Description="Type of CNV event (either Gain, Loss, or CN LoH)">
##INFO=<ID=Targets,Number=1,Type=Integer,Description="Number of targets in this event">
##INFO=<ID=Samples2,Number=1,Type=Integer,Description="Number of samples that share this event">
##INFO=<ID=Span,Number=1,Type=Integer,Description="Size of this event">
##INFO=<ID=GeneNames,Number=.,Type=String,Description="The set of unique gene names seen in all overlapping transcripts">
##INFO=<ID=GeneIDs,Number=.,Type=String,Description="The set of Entrez gene identifiers for all overlapping transcripts">
##INFO=<ID=Aliases,Number=.,Type=String,Description="Previous names for the set of genes">
##INFO=<ID=Genes,Number=1,Type=Integer,Description="The number of genes overlapping this region.">
##INFO=<ID=TranscriptNameClinicallyRelevant,Number=.,Type=String,Description="The transcript determined to be clinically relevant among those found for the variant's interaction with the gene. If the variant affects multiple genes, one transcript from each gene is selected to be clinically relevant. The clinically relevant transcript is the transcript with the longest coding sequence among the transcripts with an LRG annotation. If a gene has no transcripts that are annotated with an LRG ID, the transcript with the longest coding sequence is used. For more information on how transcripts are chosen see our <a href='http://blog.goldenhelix.com/ajesaitis/whats-in-a-name-the-intricacies-of-identifying-variants/'>blog post on the topic</a>.">
##INFO=<ID=OverlappingExonsClinicallyRelevant,Number=.,Type=String,Description="Which exons of the transcript overlapping this region, or 'All' if they all overlap. Exon numbers are always numbered from the 5' UTR to the 3' UTR.">
##INFO=<ID=HGVSg,Number=1,Type=String,Description="The associated HGVS notation using the genomic reference sequence.">
##INFO=<ID=HGVScClinicallyRelevant,Number=.,Type=String,Description="The associated HGVS coding DNA notation with the clinically relevant transcript(s).">
##INFO=<ID=HGVSpClinicallyRelevant,Number=.,Type=String,Description="The associated HGVS protein change notation with the clinically relevant transcript(s).">
##INFO=<ID=ISCNCytobandNotation,Number=1,Type=String,Description="ISCN notation describing the overlapping cytobands.">
##INFO=<ID=SequenceOntologyClinicallyRelevant,Number=1,Type=String,Description="The sequence ontology associated with the clinically relevant transcript(s).">
##INFO=<ID=RegionClinicallyRelevant,Number=1,Type=String,Description="The region in which the variant is located. When a variant overlaps multiple regions, the region with the highest precedence is given. The order of precedence is defined as (from highest to lowest): exon, utr5, utr3, intron, intergenic.">
##INFO=<ID=Region,Number=.,Type=String,Description="The genomic position of the region.">
##INFO=<ID=Span2,Number=.,Type=Integer,Description="The size of the region (Stop-Stop).">
##INFO=<ID=OverlapType,Number=1,Type=String,Description="Specifies the way in which the CNV overlaps the region. Either \"Contains Region\", \"Within Region\", \"Identical\", or \"Partial Overlap\".">
##INFO=<ID=Name,Number=.,Type=String,Description="DGV Gene Name">
##INFO=<ID=Frequency,Number=.,Type=Float,Description="Samples Count / Num. of Unique Samples">
##INFO=<ID=Type2,Number=1,Type=String,Description="Gain or Loss">
##INFO=<ID=Region2,Number=.,Type=String,Description="The genomic position of the region.">
##INFO=<ID=Span3,Number=.,Type=Integer,Description="The size of the region (Stop-Stop).">
##INFO=<ID=OverlapType2,Number=1,Type=String,Description="Specifies the way in which the CNV overlaps the region. Either \"Contains Region\", \"Within Region\", \"Identical\", or \"Partial Overlap\".">
##INFO=<ID=Type3,Number=1,Type=String,Description="">
##INFO=<ID=Frequency2,Number=.,Type=Float,Description="">
##INFO=<ID=DeletionFrequency,Number=.,Type=Float,Description="">
##INFO=<ID=DuplicationFrequency,Number=.,Type=Float,Description="">
##FORMAT=<ID=CNVState,Number=1,Type=String,Description="State of the CNV event for each sample">
##FORMAT=<ID=AvgTargetMeanDepth,Number=1,Type=Float,Description="Average mean depth of the targets in this event as reported by Coverage Statistics">
##FORMAT=<ID=AvgZScore,Number=1,Type=Float,Description="Average Z-score of the targets in this event">
##FORMAT=<ID=AvgRatio,Number=1,Type=Float,Description="Average ratio of the targets in this event">
##FORMAT=<ID=pvalue,Number=1,Type=Float,Description="Probability that z-scores at least as extreme as those in the event would occur by chance in a normal region.">
##FORMAT=<ID=GeneList,Number=.,Type=String,Description="The genes that the cnv overlaps">
##FORMAT=<ID=CriticalGeneList,Number=.,Type=String,Description="The critical genes that the cnvs overlaps, these genes have established evidence for HI/TS. HI/TS maybe come from genes and regions in clingen or from the internal catalog of gene evaluations.">
##FORMAT=<ID=ScoredGene,Number=.,Type=String,Description="The gene with the maximum score for the gene specific criteria from the critical gene list. This gene has the strongest known effect.">
##FORMAT=<ID=ScoredGeneTranscript,Number=.,Type=String,Description="The transcript for the gene that was scored">
##FORMAT=<ID=Classification,Number=1,Type=String,Description="Classification of the score, this catagorizes the score to it pathogenicity based on the thresholds of Benign: score <= -1, Likely Benign: -1 < score <= -0.9, VUS: -0.9 < score < 0.9, Likely Pathogenic: 0.9 <= score < 1, Pathogenic: score <= 1.">
##FORMAT=<ID=Criteria,Number=.,Type=String,Description="The list of all of the criteria that were applied to reach the 'Total Score' and as a result the 'Classification'.">
##INFO=<ID=END,Number=1,Type=Integer,Description="">
##FORMAT=<ID=GT,Number=1,Type=String,Description="">
##FORMAT=<ID=CN,Number=1,Type=Integer,Description="">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	H087-301222-ROCHE_S35_R
1	17634487	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=4;Span=120;GeneNames=ARHGEF10L;GeneIDs=55160;Aliases=GrinchGEF;Genes=1;TranscriptNameClinicallyRelevant=NM_018125.4;OverlappingExonsClinicallyRelevant=17;HGVSg=NC_000001.11:g.17634487_17634606dup;HGVScClinicallyRelevant=NM_018125.4:c.1731-61_1745+44dup;HGVSpClinicallyRelevant=NP_060595.3:p.P578_R582dup;ISCNCytobandNotation=dup(1)p36.13;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=17634606	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:72.2167:4.90096:1.67187:0.000122252792191317:ARHGEF10L::ARHGEF10L:NM_018125.4:VUS:2L0ThiscnvpartiallyoverlapstheARHGEF10Lgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	28280700	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=2;Span=50059;GeneNames=MED18,SESN2;GeneIDs=83667,54797;Aliases=HI95,SES2,SEST2;Genes=2;TranscriptNameClinicallyRelevant=NM_017638.3,NM_031459.5;OverlappingExonsClinicallyRelevant=1-2,10;HGVSg=NC_000001.11:g.28280700_28330758dup;HGVScClinicallyRelevant=NM_017638.3:c.1_73+23dup,NM_031459.5:c.1357-16_1443dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(1)p35.3;SequenceOntologyClinicallyRelevant=transcript_ablation,transcript_ablation;RegionClinicallyRelevant=exon,exon;END=28330758	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:86.5292:3.65745:1.48121:5.02199642377746e-05:MED18,SESN2::MED18:NM_017638.3:VUS:2L0ThiscnvpartiallyoverlapstheMED18genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	37735263	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=EPHA10;GeneIDs=284656;Genes=1;TranscriptNameClinicallyRelevant=NM_001099439.2;OverlappingExonsClinicallyRelevant=6;HGVSg=NC_000001.11:g.37735263_37735382dup;HGVScClinicallyRelevant=NM_001099439.2:c.1485_1486ins(120);HGVSpClinicallyRelevant=NP_001092909.1:p.E457_E496dup;ISCNCytobandNotation=dup(1)p34.3;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=37735382	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:82.7167:4.72786:1.82581:0.000212291164230975:EPHA10::EPHA10:NM_001099439.2:VUS:2L0ThiscnvpartiallyoverlapstheEPHA10genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	41006013	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=3;Span=120;GeneNames=CTPS1;GeneIDs=1503;Aliases=CTPS,GATD5,GATD5A,IMD24;Genes=1;TranscriptNameClinicallyRelevant=NM_001905.4;OverlappingExonsClinicallyRelevant=13;HGVSg=NC_000001.11:g.41006013_41006132dup;HGVScClinicallyRelevant=NM_001905.4:c.1253-38_1296+38dup;HGVSpClinicallyRelevant=NP_001896.2:p.V433Mfs*17;ISCNCytobandNotation=dup(1)p34.2;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=41006132	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:88.3167:5.38488:1.79696:2.37885258355954e-05:CTPS1::CTPS1:NM_001905.4:VUS:2L0ThiscnvpartiallyoverlapstheCTPS1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	68126221	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=2;Span=120;GeneNames=GNG12-AS1,WLS;GeneIDs=100289178,79971;Genes=2;TranscriptNameClinicallyRelevant=NR_040077.1,NM_024911.7;OverlappingExonsClinicallyRelevant=.,12;HGVSg=NC_000001.11:g.68126221_68126340dup;HGVScClinicallyRelevant=.,NM_024911.7:c.1517-5_1626dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(1)p31.3;SequenceOntologyClinicallyRelevant=.,transcript_ablation;RegionClinicallyRelevant=.,exon;END=68126340	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:125.817:4.88107:1.60089:0.000130371845926705:GNG12-AS1,WLS::WLS:NM_024911.7:VUS:2L0ThiscnvpartiallyoverlapstheWLSgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	102898659	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=3;Span=13587;GeneNames=COL11A1;GeneIDs=1301;Aliases=CO11A1,COLL6,DFNA37,STL2;Genes=1;TranscriptNameClinicallyRelevant=NM_001854.4;OverlappingExonsClinicallyRelevant=54-56;HGVSg=NC_000001.11:g.102898659_102912245dup;HGVScClinicallyRelevant=NM_001854.4:c.4033-33_4248+7dup;HGVSpClinicallyRelevant=NP_001845.3:p.P1346_G1417dup;ISCNCytobandNotation=dup(1)p21.1;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=102912245	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:69.925:3.40524:1.56925:0.000162503054133771:COL11A1::COL11A1:NM_001854.4:VUS:2L0ThiscnvpartiallyoverlapstheCOL11A1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	102946842	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=15110;GeneNames=COL11A1;GeneIDs=1301;Aliases=CO11A1,COLL6,DFNA37,STL2;Genes=1;TranscriptNameClinicallyRelevant=NM_001854.4;OverlappingExonsClinicallyRelevant=41-42;HGVSg=NC_000001.11:g.102946842_102961951dup;HGVScClinicallyRelevant=NM_001854.4:c.3115-32_3276+7dup;HGVSpClinicallyRelevant=NP_001845.3:p.A1040_G1093dup;ISCNCytobandNotation=dup(1)p21.1;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=102961951	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:63.375:3.23026:1.48469:0.000351186634495396:COL11A1::COL11A1:NM_001854.4:VUS:2L0ThiscnvpartiallyoverlapstheCOL11A1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	150220667	.	N	<DEL>	.	.	Type=Loss;Targets=1;Samples2=1;Span=120;GeneNames=ANP32E;GeneIDs=81611;Aliases=LANP-L,LANPL;Genes=1;TranscriptNameClinicallyRelevant=NM_030920.5;OverlappingExonsClinicallyRelevant=7;HGVSg=NC_000001.11:g.150220667_150220786del;HGVScClinicallyRelevant=NM_030920.5:c.737-25_807del;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(1)q21.2;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=150220786	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:20.4:-4.47505:0.347536:0.000438679215740269:ANP32E::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes:1
2	96025912	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=3;Span=392;GeneNames=GPAT2;GeneIDs=150763;Aliases=CT123;Genes=1;TranscriptNameClinicallyRelevant=NM_001321527.2;OverlappingExonsClinicallyRelevant=11-12;HGVSg=NC_000002.12:g.96025912_96026303dup;HGVScClinicallyRelevant=NM_001321527.2:c.1035_1238+18dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(2)q11.2;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;Region2=2:96025368-96026234;Span3=867;OverlapType2=Partial Overlap;Type3=Duplication;Frequency2=0.0035503;DeletionFrequency=0;DuplicationFrequency=0.0035503;END=96026303	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:94.7625:4.0137:1.68393:8.40716540542366e-06:GPAT2::GPAT2:NM_001321527.2:VUS:2L0ThiscnvpartiallyoverlapstheGPAT2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
4	176111580	.	N	<DEL>	.	.	Type=Loss;Targets=29;Samples2=1;Span=67999;GeneNames=WDR17;GeneIDs=116966;Genes=1;TranscriptNameClinicallyRelevant=NM_181265.4;OverlappingExonsClinicallyRelevant=2-29;HGVSg=NC_000004.12:g.176111580_176179578del;HGVScClinicallyRelevant=NM_181265.4:c.1_3851del;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(4)q34.2;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=176179578	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:50.7008:-3.88057:0.540565:2.28936077877209e-61:WDR17::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes:1
4	185150188	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=12733;GeneNames=CFAP97,SLC25A4;GeneIDs=291,57587;Aliases=AAC1,ANT,ANT 1,ANT1,MTDPS12,MTDPS12A,PEO2,PEO3,PEOA2,T1;Genes=2;TranscriptNameClinicallyRelevant=NM_020827.3,NM_001151.4;OverlappingExonsClinicallyRelevant=5,4;HGVSg=NC_000004.12:g.185150188_185162920dup;HGVScClinicallyRelevant=NM_020827.3:c.1599_*1ins(123),.;HGVSpClinicallyRelevant=NP_065878.1:p.534Sext*41,.;ISCNCytobandNotation=dup(4)q35.1;SequenceOntologyClinicallyRelevant=stop_lost,.;RegionClinicallyRelevant=exon,.;END=185162920	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:120.021:3.16557:1.43326:0.000462721052195203:CFAP97,SLC25A4::CFAP97:NM_020827.3:VUS:2L0ThiscnvpartiallyoverlapstheCFAP97genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
5	17631998	.	N	<DEL>	.	.	Type=Loss;Targets=3;Samples2=1;Span=3082;GeneNames=TAF11L13,TAF11L14;GeneIDs=112488747,112488740;Genes=2;TranscriptNameClinicallyRelevant=NM_001401695.1,NM_001401687.1;OverlappingExonsClinicallyRelevant=All,All;HGVSg=NC_000005.10:g.17631998_17635079del;HGVScClinicallyRelevant=.,.;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=del(5)p15.1;SequenceOntologyClinicallyRelevant=.,.;RegionClinicallyRelevant=.,.;Region=5:17629411-17643908;Span2=14498;OverlapType=Within Region;Name=gssvL97919;Frequency=0.0019;Type2=Loss;END=17635079	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:96.1617:-4.21618:0.527363:8.22640755375073e-09:TAF11L13,TAF11L14::.:.:Benign:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps2proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:1
7	142065578	.	N	<DEL>	.	.	Type=Loss;Targets=17;Samples2=3;Span=20756;GeneNames=MGAM;GeneIDs=8972;Aliases=MG;Genes=1;TranscriptNameClinicallyRelevant=NM_004668.3;OverlappingExonsClinicallyRelevant=.;HGVSg=NC_000007.14:g.142065578_142086333del;HGVScClinicallyRelevant=NM_004668.3:c.4618+110_4619-8287del;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(7)q34;SequenceOntologyClinicallyRelevant=intron_variant;RegionClinicallyRelevant=intron;Region=7:142041807-142099348,7:142050223-142084684,7:142060398-142099360,7:142065905-142086994;Span2=57542,34462,38963,21090;OverlapType=Within Region,Partial Overlap,Within Region,Partial Overlap;Name=gssvL119327,gssvL119329,gssvL119328,gssvL119332;Frequency=0.0441,0.0027,0.0409,0.0073;Type2=Loss,Loss,Loss,Loss;Region2=7:142060932-142093800,7:142065727-142078454,7:142078905-142086749;Span3=32869,12728,7845;OverlapType2=Within Region,Contains Region,Partial Overlap;Type3=Deletion,Deletion,Deletion;Frequency2=0.279598,0.00118343,0.00118343;DeletionFrequency=0.279598,0.00118343,0.00118343;DuplicationFrequency=0,0,0;END=142086333	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:51.2145:-2.19768:0.546069:7.45652912574834e-13:MGAM::MGAM:NM_004668.3:Benign:2F-1ThecnvdoesnotincludeanyproteincodinggenesoutsideoftheknownhaplobenignregionISCA-46375inClinGenDosageSensitivity.,1B-0.6TheCNVdoesnotoverlapthecodingregionofanygenes:1
8	7312817	.	N	<DEL>	.	.	Type=Loss;Targets=36;Samples2=1;Span=581984;GeneNames=DEFB4A,DEFB4B,DEFB103A,DEFB103B,DEFB104A,DEFB104B,DEFB105A,DEFB105B,DEFB106A,DEFB106B,DEFB107A,DEFB107B,DEFB109B,FAM66B,FAM90A7,FAM90A8,FAM90A9,FAM90A10,FAM90A14,FAM90A16,FAM90A17,FAM90A18,FAM90A19,FAM90A22,FAM90A23,PRR23D1,PRR23D2,SPAG11A,SPAG11B,USP17L1,USP17L4,ZNF705G;GeneIDs=100128890,641517,401447,645402,100131980,100289462,55894,10407,503618,503841,504180,503614,100131608,441317,645558,645572,645651,441326,441323,441324,728746,728753,441327,441328,100133251,245910,245908,245909,140596,653423,414325,1673;Genes=32;TranscriptNameClinicallyRelevant=NM_004942.4,NM_001205266.2,NM_001081551.4,NM_018661.4,NM_080389.3,NM_001040702.1,NM_152250.3,NM_001040703.3,NM_152251.4,NM_001040704.2,NM_001037668.1,NM_001040705.2,NM_001037380.2,NR_027423.2,NM_001397387.1,NM_001164450.1,NM_001164448.1,NM_001164447.1,NM_001164452.1,NM_001397396.1,NM_001397391.1,NM_001164451.1,NM_001164449.1,NM_001397382.1,NM_001397380.1,NM_001282479.1,NM_001282478.1,NM_001395484.1,NM_058201.4,NM_001256873.1,NM_001256874.1,NM_001164457.3;OverlappingExonsClinicallyRelevant=1,All,All,All,All,All,All,All,All,All,All,All,All,1-6,All,All,All,All,All,All,All,All,All,All,All,All,All,All,All,All,All,All;HGVSg=NC_000008.11:g.7312817_7894800del;HGVScClinicallyRelevant=NM_004942.4:c.1_58+30del,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.;HGVSpClinicallyRelevant=.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.;ISCNCytobandNotation=del(8)p23.1;SequenceOntologyClinicallyRelevant=transcript_ablation,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.;RegionClinicallyRelevant=exon,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.;Region=8:7087252-8197726,8:7137583-7680412,8:7172456-8078321,8:7312955-7514711,8:7329098-7598872,8:7392846-7514711,8:7399279-7788793,8:7409831-7598490,8:7477475-7598872,8:7598490-7954150;Span2=1110475,542830,905866,201757,269775,121866,389515,188660,121398,355661;OverlapType=Within Region,Partial Overlap,Within Region,Contains Region,Contains Region,Contains Region,Contains Region,Contains Region,Contains Region,Partial Overlap;Name=gssvL122331,gssvL122335,gssvL122332,gssvL122347,gssvL122341,gssvL122355,gssvL122336,gssvL122348,gssvL122353,gssvL122339;Frequency=0.0233,0.0009,0.044,0.005,0.0059,0.0079,0.0017,0.0069,0.0007,0.0005;Type2=Loss,Loss,Loss,Loss,Loss,Loss,Loss,Loss,Loss,Loss;END=7894800	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:44.0487:-1.48014:0.486694:1.92318240403684e-12:DEFB4A,DEFB4B,DEFB103A,DEFB103B,DEFB104A,DEFB104B,DEFB105A,DEFB105B,DEFB106A,DEFB106B,DEFB107A,DEFB107B,DEFB109B,FAM66B,FAM90A7,FAM90A8,FAM90A9,FAM90A10,FAM90A14,FAM90A16,FAM90A17,FAM90A18,FAM90A19,FAM90A22,FAM90A23,PRR23D1,PRR23D2,SPAG11A,SPAG11B,USP17L1,USP17L4,ZNF705G::DEFB4B:NM_001205266.2:VUS:2F-1ThecnviscompletelycontainedinthehaplobenignregionISCA-37472inClinGenDosageSensitivity.,3B0.45Thiscnvoverlaps31proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:1
8	143213234	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=GPIHBP1;GeneIDs=338328;Aliases=GPI-HBP1,HYPL1D;Genes=1;TranscriptNameClinicallyRelevant=NM_178172.6;OverlappingExonsClinicallyRelevant=1;HGVSg=NC_000008.11:g.143213234_143213353dup;HGVScClinicallyRelevant=NM_178172.6:c.1_52+34dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(8)q24.3;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=143213353	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:130.508:4.81641:1.64487:0.000160427049373229:GPIHBP1::GPIHBP1:NM_178172.6:VUS:2L0ThiscnvpartiallyoverlapstheGPIHBP1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
9	37495879	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=2339;GeneNames=POLR1E;GeneIDs=64425;Aliases=A49,PAF53,PRAF1,RPA49;Genes=1;TranscriptNameClinicallyRelevant=NM_022490.4;OverlappingExonsClinicallyRelevant=8-9;HGVSg=NC_000009.12:g.37495879_37498217dup;HGVScClinicallyRelevant=NM_022490.4:c.656-11_879dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(9)p13.2;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=37498217	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:141.887:3.26584:1.38528:0.000301146208271417:POLR1E::POLR1E:NM_022490.4:VUS:2L0ThiscnvpartiallyoverlapsthePOLR1Egenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
10	122488892	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=HTRA1;GeneIDs=5654;Aliases=ARMD7,CADASIL2,CARASIL,HtrA,L56,ORF480,PRSS11;Genes=1;TranscriptNameClinicallyRelevant=NM_002775.5;OverlappingExonsClinicallyRelevant=2;HGVSg=NC_000010.11:g.122488892_122489011dup;HGVScClinicallyRelevant=NM_002775.5:c.473-10_572+10dup;HGVSpClinicallyRelevant=NP_002766.1:p.L192Afs*10;ISCNCytobandNotation=dup(10)q26.13;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=122489011	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:100.808:4.66713:1.6131:0.000256563734555511:HTRA1::HTRA1:NM_002775.5:VUS:2L0ThiscnvpartiallyoverlapstheHTRA1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
10	122585210	.	N	<DUP>	.	.	Type=Gain;Targets=7;Samples2=14;Span=8410;GeneNames=DMBT1;GeneIDs=1755;Aliases=GP340,SALSA,muclin;Genes=1;TranscriptNameClinicallyRelevant=NM_007329.3;OverlappingExonsClinicallyRelevant=15-21;HGVSg=NC_000010.11:g.122585210_122593619dup;HGVScClinicallyRelevant=NM_007329.3:c.1421-61_2530+21dup;HGVSpClinicallyRelevant=NP_015568.2:p.L476_T845dup;ISCNCytobandNotation=dup(10)q26.13;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;Region=10:122574679-122601166,10:122582018-122593721;Span2=26488,11704;OverlapType=Within Region,Within Region;Name=gssvG5523,gssvG5527;Frequency=0.0154,0.2473;Type2=Gain,Gain;Region2=10:122580797-122600886,10:122581021-122600273,10:122583014-122591771;Span3=20090,19253,8758;OverlapType2=Within Region,Within Region,Partial Overlap;Type3=Duplication,Duplication,Duplication;Frequency2=0.966667,0.75,0.025;DeletionFrequency=0,0,0;DuplicationFrequency=0.966667,0.75,0.025;END=122593619	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:281.096:1.80786:1.45303:0.000186016428082016:DMBT1::DMBT1:NM_007329.3:Benign:2L0ThiscnvpartiallyoverlapstheDMBT1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
11	117228223	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=PCSK7;GeneIDs=9159;Aliases=LPC,PC7,PC8,SPC7;Genes=1;TranscriptNameClinicallyRelevant=NM_004716.4;OverlappingExonsClinicallyRelevant=4;HGVSg=NC_000011.10:g.117228223_117228342dup;HGVScClinicallyRelevant=NM_004716.4:c.596_597ins(120);HGVSpClinicallyRelevant=NP_004707.2:p.R160_P199dup;ISCNCytobandNotation=dup(11)q23.3;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=117228342	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:125.817:5.26131:1.73714:3.66131963424979e-05:PCSK7::PCSK7:NM_004716.4:VUS:2L0ThiscnvpartiallyoverlapsthePCSK7genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
12	51812641	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=SCN8A;GeneIDs=6334;Aliases=BFIS5,CERIII,CIAT,DEE13,EIEE13,MED,MYOCL2,NaCh6,Nav1.6,PN4;Genes=1;TranscriptNameClinicallyRelevant=NM_014191.4;OverlappingExonsClinicallyRelevant=27;HGVSg=NC_000012.12:g.51812641_51812760dup;HGVScClinicallyRelevant=.;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(12)q13.13;SequenceOntologyClinicallyRelevant=.;RegionClinicallyRelevant=.;END=51812760	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:114.292:4.55401:1.75009:0.000363016331690703:SCN8A::.:.:VUS:1B-0.6TheCNVdoesnotoverlapthecodingregionofanygenes,3A0Thiscnvoverlaps1proteincodinggenes:3
12	57037540	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=MYO1A;GeneIDs=4640;Aliases=BBMI,DFNA48,MIHC,MYHL;Genes=1;TranscriptNameClinicallyRelevant=NM_005379.4;OverlappingExonsClinicallyRelevant=19;HGVSg=NC_000012.12:g.57037540_57037659dup;HGVScClinicallyRelevant=NM_005379.4:c.1962-18_2055+8dup;HGVSpClinicallyRelevant=NP_005370.1:p.L686Gfs*4;ISCNCytobandNotation=dup(12)q13.3;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=57037659	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:106.908:5.20443:1.59526:4.45150168977336e-05:MYO1A::MYO1A:NM_005379.4:VUS:2L0ThiscnvpartiallyoverlapstheMYO1Agenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
12	57772716	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=1;Span=2042;GeneNames=EEF1AKMT3;GeneIDs=25895;Aliases=FAM119B,METTL21B;Genes=1;TranscriptNameClinicallyRelevant=NM_015433.3;OverlappingExonsClinicallyRelevant=1-2;HGVSg=NC_000012.12:g.57772716_57774757dup;HGVScClinicallyRelevant=NM_015433.3:c.1_289+1629dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(12)q14.1;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=57774757	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:86.5093:3.00448:1.41266:4.55100339708222e-05:EEF1AKMT3::EEF1AKMT3:NM_015433.3:VUS:2L0ThiscnvpartiallyoverlapstheEEF1AKMT3genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
15	82241277	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=EFL1;GeneIDs=79631;Aliases=EFTUD1,FAM42A,HsT19294,RIA1,SDS2;Genes=1;TranscriptNameClinicallyRelevant=NM_024580.6;OverlappingExonsClinicallyRelevant=5;HGVSg=NC_000015.10:g.82241277_82241396dup;HGVScClinicallyRelevant=NM_024580.6:c.371_372ins(120);HGVSpClinicallyRelevant=NP_078856.4:p.V123_C124ins40;ISCNCytobandNotation=dup(15)q25.2;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=82241396	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:103.383:4.71077:1.66497:0.000223961886579499:EFL1::EFL1:NM_024580.6:VUS:2L0ThiscnvpartiallyoverlapstheEFL1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
16	14895520	.	N	<DEL>	.	.	Type=Loss;Targets=20;Samples2=1;Span=127270;GeneNames=LOC100288162,MIR1972-1,MIR3179-1,MIR3180-1,MIR3670-1,MIR6511A1,MIR6770-1,NOMO1,NPIPA1,PDXDC1,PKD1P3-NPIPA1;GeneIDs=23420,100422960,100500910,100422870,109951030,100288162,102466268,102465461,9284,23042,100302243;Aliases=Nomo,PM5;Genes=11;TranscriptNameClinicallyRelevant=NR_103772.1,NR_036054.1,NR_036140.1,NR_036141.1,NR_037442.1,NR_106766.1,NR_106828.1,NM_014287.4,NM_006985.4,NM_015027.4,NR_146231.1;OverlappingExonsClinicallyRelevant=All,All,All,All,All,All,All,31,All,1-13,All;HGVSg=NC_000016.10:g.14895520_15022789del;HGVScClinicallyRelevant=.,.,.,.,.,.,.,NM_014287.4:c.3544_3669del,.,NM_015027.4:c.1_1140+35del,.;HGVSpClinicallyRelevant=.,.,.,.,.,.,.,NP_055102.3:p.P1182Gext*18,.,.,.;ISCNCytobandNotation=del(16)p13.11;SequenceOntologyClinicallyRelevant=.,.,.,.,.,.,.,stop_lost,.,transcript_ablation,.;RegionClinicallyRelevant=.,.,.,.,.,.,.,exon,.,exon,.;Region=16:14835288-14983611,16:14845471-15034129,16:14885100-15322653,16:14914934-15033033,16:14947089-15022388,16:14954899-14993308;Span2=148324,188659,437554,118100,75300,38410;OverlapType=Partial Overlap,Within Region,Within Region,Partial Overlap,Contains Region,Contains Region;Name=gssvL42901,gssvL42897,gssvL42890,gssvL42902,gssvL42911,gssvL42915;Frequency=0.0009,0.0088,0.0003,0.0096,0.0024,0.0098;Type2=Loss,Loss,Loss,Loss,Loss,Loss;Region2=16:14954884-15030232;Span3=75349;OverlapType2=Partial Overlap;Type3=Deletion;Frequency2=0.05;DeletionFrequency=0.05;DuplicationFrequency=0;END=15022789	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:42.5715:-1.57622:0.553513:2.39789850390675e-08:LOC100288162,MIR1972-1,MIR3179-1,MIR3180-1,MIR3670-1,MIR6511A1,MIR6770-1,NOMO1,NPIPA1,PDXDC1,PKD1P3-NPIPA1::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps3proteincodinggenes:1
16	29393952	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=1;Span=9850;GeneNames=NPIPB11;GeneIDs=728888;Aliases=NPIP;Genes=1;TranscriptNameClinicallyRelevant=NM_001310137.5;OverlappingExonsClinicallyRelevant=2-3;HGVSg=NC_000016.10:g.29393952_29403801dup;HGVScClinicallyRelevant=NM_001310137.5:c.120+9731_120+9732ins(9850);HGVSpClinicallyRelevant=NP_001297066.2:p.M1Ffs*6;ISCNCytobandNotation=dup(16)p11.2;SequenceOntologyClinicallyRelevant=initiator_codon_variant;RegionClinicallyRelevant=exon;END=29403801	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:188.233:2.93689:1.37086:6.76022717273228e-05:NPIPB11::NPIPB11:NM_001310137.5:VUS:2L0ThiscnvpartiallyoverlapstheNPIPB11genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
16	70130423	.	N	<DUP>	.	.	Type=Gain;Targets=9;Samples2=1;Span=15356;GeneNames=PDPR;GeneIDs=55066;Aliases=PDP3;Genes=1;TranscriptNameClinicallyRelevant=NM_017990.5;OverlappingExonsClinicallyRelevant=7-15;HGVSg=NC_000016.10:g.70130423_70145778dup;HGVScClinicallyRelevant=NM_017990.5:c.608_1868-356dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(16)q22.1;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;Region=16:70111451-70179141;Span2=67691;OverlapType=Within Region;Name=gssvG15182;Frequency=0.0647;Type2=Gain;Region2=16:70106838-70177676,16:70111452-70162599,16:70130436-70143532;Span3=70839,51148,13097;OverlapType2=Within Region,Within Region,Contains Region;Type3=Duplication,Duplication,Duplication;Frequency2=0.00523737,0.755556,0.00118343;DeletionFrequency=0,0,0;DuplicationFrequency=0.00523737,0.755556,0.00118343;END=70145778	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:151.654:1.94138:1.40531:5.07401482628587e-06:PDPR::PDPR:NM_017990.5:VUS:2E0TheCNVissmallerthanthetriplobenignregionISCA-46493inClinGenDosageSensitivityandpotentiallyinteruptsprotein-codinggenePDPR.,2L0ThiscnvpartiallyoverlapsthePDPRgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
16	70148448	.	N	<DUP>	.	.	Type=Gain;Targets=9;Samples2=1;Span=38114;GeneNames=CLEC18C,LOC400541,PDPR;GeneIDs=55066,400541,283971;Aliases=PDP3;Genes=3;TranscriptNameClinicallyRelevant=NM_173619.4,NR_126007.1,NM_017990.5;OverlappingExonsClinicallyRelevant=All,All,17-19;HGVSg=NC_000016.10:g.70148448_70186561dup;HGVScClinicallyRelevant=.,.,NM_017990.5:c.1963-16_2640dup;HGVSpClinicallyRelevant=.,.,.;ISCNCytobandNotation=dup(16)q22.1;SequenceOntologyClinicallyRelevant=.,.,transcript_ablation;RegionClinicallyRelevant=.,.,exon;Region=16:70090445-70251178,16:70111451-70179141,16:70141045-70164354,16:70142379-70179141;Span2=160734,67691,23310,36763;OverlapType=Within Region,Partial Overlap,Partial Overlap,Partial Overlap;Name=gssvG15176,gssvG15182,gssvG15193,gssvG15186;Frequency=0.0038,0.0647,0.4569,0.002;Type2=Gain,Gain,Gain,Gain;Region2=16:70106838-70177676,16:70117625-70247875,16:70145441-70179141,16:70173278-70203714;Span3=70839,130251,33701,30437;OverlapType2=Partial Overlap,Within Region,Partial Overlap,Partial Overlap;Type3=Duplication,Duplication,Duplication,Duplication;Frequency2=0.00523737,0.00101369,0.00067579,0.00118343;DeletionFrequency=0,0,0,0;DuplicationFrequency=0.00523737,0.00101369,0.00067579,0.00118343;END=70186561	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:163.479:1.61708:1.39083:0.000151166763730198:CLEC18C,LOC400541,PDPR::PDPR:NM_017990.5:Benign:2E0TheCNVissmallerthanthetriplobenignregionISCA-46493inClinGenDosageSensitivityandpotentiallyinteruptsprotein-codinggenePDPR.,2L0ThiscnvpartiallyoverlapsthePDPRgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
16	74385337	.	N	<DUP>	.	.	Type=Gain;Targets=10;Samples2=5;Span=25307;GeneNames=CLEC18B,LOC105376772,NPIPB15;GeneIDs=440348,105376772,497190;Aliases=A-761H5.4,NPIPL2;Genes=3;TranscriptNameClinicallyRelevant=NM_001385193.1,NR_135170.1,NM_001306094.2;OverlappingExonsClinicallyRelevant=10-12,All,4-8;HGVSg=NC_000016.10:g.74385337_74410643dup;HGVScClinicallyRelevant=NM_001385193.1:c.1115-11_1341dup,.,NM_001306094.2:c.250-5_1332dup;HGVSpClinicallyRelevant=.,.,.;ISCNCytobandNotation=dup(16)q23.1;SequenceOntologyClinicallyRelevant=transcript_ablation,.,transcript_ablation;RegionClinicallyRelevant=exon,.,exon;Region=16:74337368-74432521,16:74359803-74400402,16:74393258-74431487;Span2=95154,40600,38230;OverlapType=Within Region,Partial Overlap,Partial Overlap;Name=gssvG15270,gssvG15273,gssvG15274;Frequency=0.0697,0.7163,1;Type2=Gain,Gain,Gain;Region2=16:74305874-74429541,16:74363161-74469071,16:74374985-74396665,16:74381476-74391699;Span3=123668,105911,21681,10224;OverlapType2=Within Region,Within Region,Partial Overlap,Partial Overlap;Type3=Duplication,Duplication,Duplication,Duplication;Frequency2=0.1,0.000168947,0.025,0.0035503;DeletionFrequency=0,0,0,0;DuplicationFrequency=0.1,0.000168947,0.025,0.0035503;END=74410643	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:243.812:1.41844:1.3331:0.000470348087693819:CLEC18B,LOC105376772,NPIPB15::CLEC18B:NM_001385193.1:Benign:2E0TheCNVissmallerthanthetriplobenignregionISCA-46693inClinGenDosageSensitivityandpotentiallyinteruptsprotein-codinggeneCLEC18B.,2L0ThiscnvpartiallyoverlapstheCLEC18Bgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
17	18151839	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=3;Span=370;GeneNames=MYO15A;GeneIDs=51168;Aliases=DFNB3,MYO15;Genes=1;TranscriptNameClinicallyRelevant=NM_016239.4;OverlappingExonsClinicallyRelevant=41-42;HGVSg=NC_000017.11:g.18151839_18152208dup;HGVScClinicallyRelevant=NM_016239.4:c.7788-7_7966+24dup;HGVSpClinicallyRelevant=NP_057323.3:p.A2656Gfs*9;ISCNCytobandNotation=dup(17)p11.2;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=18152208	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:96.7167:3.26075:1.49271:0.00030785187428781:MYO15A::MYO15A:NM_016239.4:VUS:2B0WhiletheCNVoverlapstheMYO15AgeneitisunclearifthisisthecausativegeneforhaploinsufficientregionISCA-37418inClinGenDosageSensitivity.,2L0ThiscnvpartiallyoverlapstheMYO15Agenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
17	29092339	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=MYO18A;GeneIDs=399687;Aliases=MAJN,MYSPDZ,SP-R210,SPR210,TIAF1;Genes=1;TranscriptNameClinicallyRelevant=NM_078471.4;OverlappingExonsClinicallyRelevant=34;HGVSg=NC_000017.11:g.29092339_29092458dup;HGVScClinicallyRelevant=NM_078471.4:c.5074-2_5187+4dup;HGVSpClinicallyRelevant=NP_510880.2:p.S1695_E1732dup;ISCNCytobandNotation=dup(17)q11.2;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=29092458	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:117.842:4.54982:1.66434:0.000367668269029007:MYO18A::MYO18A:NM_078471.4:VUS:2L0ThiscnvpartiallyoverlapstheMYO18Agenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
17	45971843	.	N	<DEL>	.	.	Type=Loss;Targets=3;Samples2=1;Span=6624;GeneNames=MAPT;GeneIDs=4137;Aliases=DDPAC,FTDP-17,MAPTL,MSTD,MTBT1,MTBT2,PPND,PPP1R103,TAU,tau-40;Genes=1;TranscriptNameClinicallyRelevant=NM_005910.6;OverlappingExonsClinicallyRelevant=3-5;HGVSg=NC_000017.11:g.45971843_45978466del;HGVScClinicallyRelevant=NM_005910.6:c.134-16_373+26del;HGVSpClinicallyRelevant=NP_005901.2:p.E45_Q124del;ISCNCytobandNotation=del(17)q21.31;SequenceOntologyClinicallyRelevant=inframe_deletion;RegionClinicallyRelevant=exon;END=45978466	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:34.8278:-2.84635:0.563406:0.000103488843514539:MAPT::MAPT:NM_005910.6:VUS:2B0WhiletheCNVoverlapstheMAPTgeneitisunclearifthisisthecausativegeneforhaploinsufficientregionISCA-37420inClinGenDosageSensitivity.,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:1
21	36751237	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=1;Span=636;GeneNames=HLCS;GeneIDs=3141;Aliases=HCS;Genes=1;TranscriptNameClinicallyRelevant=NM_000411.8;OverlappingExonsClinicallyRelevant=12;HGVSg=NC_000021.9:g.36751237_36751872dup;HGVScClinicallyRelevant=.;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(21)q22.13;SequenceOntologyClinicallyRelevant=.;RegionClinicallyRelevant=.;END=36751872	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:120.438:3.41056:1.38841:8.39548869140524e-08:HLCS::.:.:VUS:1B-0.6TheCNVdoesnotoverlapthecodingregionofanygenes,3A0Thiscnvoverlaps1proteincodinggenes:3
22	20717683	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=10;Span=1134;GeneNames=PI4KA;GeneIDs=5297;Aliases=GIDID2,PI4K-ALPHA,PIK4CA,PMGYCHA,SPG84,pi4K230;Genes=1;TranscriptNameClinicallyRelevant=NM_058004.4;OverlappingExonsClinicallyRelevant=44-45;HGVSg=NC_000022.11:g.20717683_20718816dup;HGVScClinicallyRelevant=NM_058004.4:c.5123_5317+25dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(22)q11.21;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=20718816	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:71.4292:3.45007:1.69793:0.000132617863924131:PI4KA::PI4KA:NM_058004.4:VUS:2B0WhiletheCNVoverlapsthePI4KAgeneitisunclearifthisisthecausativegeneforhaploinsufficientregionISCA-37446inClinGenDosageSensitivity.,2L0ThiscnvpartiallyoverlapsthePI4KAgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
22	23957713	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=3;Span=2685;GeneNames=GSTT2B;GeneIDs=653689;Aliases=GSTT2P;Genes=1;TranscriptNameClinicallyRelevant=NM_001080843.4;OverlappingExonsClinicallyRelevant=2-5;HGVSg=NC_000022.11:g.23957713_23960397dup;HGVScClinicallyRelevant=NM_001080843.4:c.113-16_735dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(22)q11.23;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=23960397	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:283.538:2.61308:1.43503:0.000402304066426664:GSTT2B::GSTT2B:NM_001080843.4:Benign:2L0ThiscnvpartiallyoverlapstheGSTT2Bgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
22	31399645	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=DRG1;GeneIDs=4733;Aliases=NEDD3;Genes=1;TranscriptNameClinicallyRelevant=NM_004147.4;OverlappingExonsClinicallyRelevant=1;HGVSg=NC_000022.11:g.31399645_31399764dup;HGVScClinicallyRelevant=NM_004147.4:c.1_42+39dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(22)q12.2;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=31399764	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:138.375:5.13886:1.6175:5.56302837654986e-05:DRG1::DRG1:NM_004147.4:VUS:2L0ThiscnvpartiallyoverlapstheDRG1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
22	39042927	.	N	<DEL>	.	.	Type=Loss;Targets=1;Samples2=1;Span=172;GeneNames=APOBEC3F;GeneIDs=200316;Aliases=A3F,ARP8,BK150C2.4.MRNA,KA6;Genes=1;TranscriptNameClinicallyRelevant=NM_145298.6;OverlappingExonsClinicallyRelevant=2;HGVSg=NC_000022.11:g.39042927_39043098del;HGVScClinicallyRelevant=NM_145298.6:c.18-10_171+8del;HGVSpClinicallyRelevant=NP_660341.2:p.N7Cfs*58;ISCNCytobandNotation=del(22)q13.1;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=39043098	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:47.9884:-4.96562:0.446256:9.38974911459658e-05:APOBEC3F::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes:1
